nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—DRD4—Gilles de la Tourette syndrome	0.209	0.269	CbGaD
Loxapine—DRD3—Gilles de la Tourette syndrome	0.18	0.232	CbGaD
Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.168	0.216	CbGaD
Loxapine—DRD2—Gilles de la Tourette syndrome	0.125	0.16	CbGaD
Loxapine—HTR2A—Gilles de la Tourette syndrome	0.0965	0.124	CbGaD
Loxapine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00332	0.0499	CbGeAlD
Loxapine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.0032	0.0481	CbGeAlD
Loxapine—HTR5A—nervous system—Gilles de la Tourette syndrome	0.0026	0.0391	CbGeAlD
Loxapine—HTR5A—central nervous system—Gilles de la Tourette syndrome	0.0025	0.0376	CbGeAlD
Loxapine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00199	0.03	CbGeAlD
Loxapine—HTR5A—brain—Gilles de la Tourette syndrome	0.00198	0.0299	CbGeAlD
Loxapine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00111	0.0167	CbGeAlD
Loxapine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00107	0.0161	CbGeAlD
Loxapine—DRD4—brain—Gilles de la Tourette syndrome	0.000983	0.0148	CbGeAlD
Loxapine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.000972	0.0146	CbGeAlD
Loxapine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.000936	0.0141	CbGeAlD
Loxapine—DRD3—nervous system—Gilles de la Tourette syndrome	0.000904	0.0136	CbGeAlD
Loxapine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00087	0.0131	CbGeAlD
Loxapine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00087	0.0131	CbGeAlD
Loxapine—HTR1E—brain—Gilles de la Tourette syndrome	0.000847	0.0128	CbGeAlD
Loxapine—DRD5—nervous system—Gilles de la Tourette syndrome	0.000847	0.0128	CbGeAlD
Loxapine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.000837	0.0126	CbGeAlD
Loxapine—DRD5—central nervous system—Gilles de la Tourette syndrome	0.000815	0.0123	CbGeAlD
Loxapine—HRH2—nervous system—Gilles de la Tourette syndrome	0.000795	0.012	CbGeAlD
Loxapine—DRD1—midbrain—Gilles de la Tourette syndrome	0.000787	0.0119	CbGeAlD
Loxapine—HRH2—central nervous system—Gilles de la Tourette syndrome	0.000766	0.0115	CbGeAlD
Loxapine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.00076	0.0114	CbGeAlD
Loxapine—CHRM4—brain—Gilles de la Tourette syndrome	0.000743	0.0112	CbGeAlD
Loxapine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000731	0.011	CbGeAlD
Loxapine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000694	0.0105	CbGeAlD
Loxapine—DRD3—brain—Gilles de la Tourette syndrome	0.000691	0.0104	CbGeAlD
Loxapine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000668	0.0101	CbGeAlD
Loxapine—HTR6—brain—Gilles de la Tourette syndrome	0.000665	0.01	CbGeAlD
Loxapine—DRD5—brain—Gilles de la Tourette syndrome	0.000647	0.00975	CbGeAlD
Loxapine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000647	0.00974	CbGeAlD
Loxapine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000638	0.0096	CbGeAlD
Loxapine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.000633	0.00952	CbGeAlD
Loxapine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000625	0.00941	CbGeAlD
Loxapine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000623	0.00938	CbGeAlD
Loxapine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000617	0.0093	CbGeAlD
Loxapine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000611	0.00921	CbGeAlD
Loxapine—HRH2—brain—Gilles de la Tourette syndrome	0.000608	0.00915	CbGeAlD
Loxapine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000602	0.00906	CbGeAlD
Loxapine—Asenapine—DRD4—Gilles de la Tourette syndrome	0.000581	0.0901	CrCbGaD
Loxapine—CHRM5—brain—Gilles de la Tourette syndrome	0.000581	0.00874	CbGeAlD
Loxapine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00058	0.00873	CbGeAlD
Loxapine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000531	0.00799	CbGeAlD
Loxapine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000524	0.00789	CbGeAlD
Loxapine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000522	0.00785	CbGeAlD
Loxapine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.00052	0.00783	CbGeAlD
Loxapine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000515	0.00775	CbGeAlD
Loxapine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000508	0.00764	CbGeAlD
Loxapine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000505	0.0076	CbGeAlD
Loxapine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000503	0.00757	CbGeAlD
Loxapine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000502	0.00756	CbGeAlD
Loxapine—Asenapine—DRD3—Gilles de la Tourette syndrome	0.000501	0.0777	CrCbGaD
Loxapine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000501	0.00754	CbGeAlD
Loxapine—DRD1—brain—Gilles de la Tourette syndrome	0.000495	0.00745	CbGeAlD
Loxapine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.000493	0.00743	CbGeAlD
Loxapine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000492	0.00741	CbGeAlD
Loxapine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000489	0.00736	CbGeAlD
Loxapine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000484	0.00729	CbGeAlD
Loxapine—HTR3A—brain—Gilles de la Tourette syndrome	0.000478	0.00719	CbGeAlD
Loxapine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000477	0.00718	CbGeAlD
Loxapine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.000475	0.00715	CbGeAlD
Loxapine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000475	0.00715	CbGeAlD
Loxapine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000465	0.007	CbGeAlD
Loxapine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000459	0.00691	CbGeAlD
Loxapine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000457	0.00688	CbGeAlD
Loxapine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000452	0.00681	CbGeAlD
Loxapine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000425	0.0064	CbGeAlD
Loxapine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000423	0.00637	CbGeAlD
Loxapine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00042	0.00632	CbGeAlD
Loxapine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000409	0.00616	CbGeAlD
Loxapine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000407	0.00613	CbGeAlD
Loxapine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000404	0.00609	CbGeAlD
Loxapine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000404	0.00608	CbGeAlD
Loxapine—HTR1B—brain—Gilles de la Tourette syndrome	0.000401	0.00603	CbGeAlD
Loxapine—CHRM2—brain—Gilles de la Tourette syndrome	0.000399	0.006	CbGeAlD
Loxapine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000397	0.00599	CbGeAlD
Loxapine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00039	0.00587	CbGeAlD
Loxapine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000389	0.00586	CbGeAlD
Loxapine—HTR1D—brain—Gilles de la Tourette syndrome	0.000388	0.00584	CbGeAlD
Loxapine—HTR2C—brain—Gilles de la Tourette syndrome	0.000384	0.00579	CbGeAlD
Loxapine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000382	0.00576	CbGeAlD
Loxapine—ADRB1—brain—Gilles de la Tourette syndrome	0.000377	0.00568	CbGeAlD
Loxapine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000376	0.00565	CbGeAlD
Loxapine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000372	0.0056	CbGeAlD
Loxapine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000368	0.00554	CbGeAlD
Loxapine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000364	0.00548	CbGeAlD
Loxapine—CHRM1—brain—Gilles de la Tourette syndrome	0.000363	0.00546	CbGeAlD
Loxapine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000361	0.00543	CbGeAlD
Loxapine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000358	0.00539	CbGeAlD
Loxapine—Asenapine—DRD2—Gilles de la Tourette syndrome	0.000347	0.0538	CrCbGaD
Loxapine—CHRM3—brain—Gilles de la Tourette syndrome	0.000325	0.00489	CbGeAlD
Loxapine—HTR1A—brain—Gilles de la Tourette syndrome	0.000323	0.00487	CbGeAlD
Loxapine—Olanzapine—DRD4—Gilles de la Tourette syndrome	0.000323	0.0501	CrCbGaD
Loxapine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000321	0.00483	CbGeAlD
Loxapine—HTR7—brain—Gilles de la Tourette syndrome	0.000309	0.00465	CbGeAlD
Loxapine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000307	0.00462	CbGeAlD
Loxapine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000302	0.00455	CbGeAlD
Loxapine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000298	0.00449	CbGeAlD
Loxapine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000297	0.00447	CbGeAlD
Loxapine—DRD2—brain—Gilles de la Tourette syndrome	0.000292	0.0044	CbGeAlD
Loxapine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000291	0.00438	CbGeAlD
Loxapine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000286	0.0043	CbGeAlD
Loxapine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000284	0.00428	CbGeAlD
Loxapine—Olanzapine—DRD3—Gilles de la Tourette syndrome	0.000279	0.0432	CrCbGaD
Loxapine—Asenapine—HTR2A—Gilles de la Tourette syndrome	0.000268	0.0415	CrCbGaD
Loxapine—Amoxapine—DRD4—Gilles de la Tourette syndrome	0.000257	0.0399	CrCbGaD
Loxapine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000252	0.0038	CbGeAlD
Loxapine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000243	0.00366	CbGeAlD
Loxapine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000241	0.0374	CrCbGaD
Loxapine—HRH1—brain—Gilles de la Tourette syndrome	0.000231	0.00347	CbGeAlD
Loxapine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000227	0.00341	CbGeAlD
Loxapine—Amoxapine—DRD3—Gilles de la Tourette syndrome	0.000222	0.0344	CrCbGaD
Loxapine—Amoxapine—SLC6A3—Gilles de la Tourette syndrome	0.000206	0.032	CrCbGaD
Loxapine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000203	0.0314	CrCbGaD
Loxapine—Cyproheptadine—DRD2—Gilles de la Tourette syndrome	0.000199	0.0309	CrCbGaD
Loxapine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.000196	0.0304	CrCbGaD
Loxapine—Olanzapine—DRD2—Gilles de la Tourette syndrome	0.000193	0.0299	CrCbGaD
Loxapine—HTR2A—brain—Gilles de la Tourette syndrome	0.000193	0.0029	CbGeAlD
Loxapine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000175	0.0271	CrCbGaD
Loxapine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000169	0.0262	CrCbGaD
Loxapine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000169	0.0262	CrCbGaD
Loxapine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000167	0.0259	CrCbGaD
Loxapine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0243	CrCbGaD
Loxapine—Cyproheptadine—HTR2A—Gilles de la Tourette syndrome	0.000154	0.0239	CrCbGaD
Loxapine—Amoxapine—DRD2—Gilles de la Tourette syndrome	0.000154	0.0238	CrCbGaD
Loxapine—Olanzapine—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0231	CrCbGaD
Loxapine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000145	0.0226	CrCbGaD
Loxapine—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.000144	0.0223	CrCbGaD
Loxapine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000135	0.0209	CrCbGaD
Loxapine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000121	0.0187	CrCbGaD
Loxapine—Amoxapine—HTR2A—Gilles de la Tourette syndrome	0.000119	0.0184	CrCbGaD
Loxapine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.000117	0.0181	CrCbGaD
Loxapine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000101	0.0156	CrCbGaD
Loxapine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	9.32e-05	0.0145	CrCbGaD
Loxapine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	9.04e-05	0.014	CrCbGaD
Loxapine—Clozapine—HTR2A—Gilles de la Tourette syndrome	7.78e-05	0.0121	CrCbGaD
Loxapine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.000165	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.43e-05	0.000164	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000164	CbGpPWpGaD
Loxapine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.41e-05	0.000162	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.39e-05	0.000161	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.39e-05	0.000161	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000161	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.37e-05	0.00016	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000159	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.000159	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.34e-05	0.000158	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.34e-05	0.000158	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.32e-05	0.000157	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000156	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.29e-05	0.000154	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000154	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000154	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.27e-05	0.000153	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.27e-05	0.000153	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.26e-05	0.000153	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.26e-05	0.000152	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.25e-05	0.000151	CbGpPWpGaD
Loxapine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.22e-05	0.00015	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.19e-05	0.000148	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.18e-05	0.000147	CbGpPWpGaD
Loxapine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.18e-05	0.000147	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.18e-05	0.000147	CbGpPWpGaD
Loxapine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000147	CbGpPWpGaD
Loxapine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000146	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.17e-05	0.000146	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.16e-05	0.000145	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.15e-05	0.000145	CbGpPWpGaD
Loxapine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.15e-05	0.000145	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.14e-05	0.000144	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000144	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.13e-05	0.000144	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.12e-05	0.000143	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000143	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.09e-05	0.000141	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.08e-05	0.00014	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.00014	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.06e-05	0.000139	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.06e-05	0.000139	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000138	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.04e-05	0.000138	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000137	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.03e-05	0.000137	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000134	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.98e-05	0.000134	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.98e-05	0.000134	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.98e-05	0.000133	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.95e-05	0.000132	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.95e-05	0.000131	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.95e-05	0.000131	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000131	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000131	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000131	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.93e-05	0.00013	CbGpPWpGaD
Loxapine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.00013	CbGpPWpGaD
Loxapine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.00013	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.93e-05	0.00013	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.93e-05	0.00013	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.92e-05	0.00013	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000129	CbGpPWpGaD
Loxapine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.92e-05	0.000129	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000129	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.91e-05	0.000129	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.91e-05	0.000129	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.9e-05	0.000128	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.89e-05	0.000128	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.89e-05	0.000127	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000127	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000127	CbGpPWpGaD
Loxapine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000127	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.86e-05	0.000125	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Loxapine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000124	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000123	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.8e-05	0.000121	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.79e-05	0.000121	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.00012	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.000119	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.000119	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.77e-05	0.000119	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.76e-05	0.000119	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.000119	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.76e-05	0.000119	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.000118	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.000118	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.000118	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.000118	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.000118	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.75e-05	0.000118	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000118	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000117	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000117	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.74e-05	0.000117	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.73e-05	0.000117	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.73e-05	0.000117	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.73e-05	0.000116	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000116	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000116	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000116	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.71e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.7e-05	0.000115	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.7e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.69e-05	0.000114	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.68e-05	0.000113	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.68e-05	0.000113	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000112	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000112	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000111	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.64e-05	0.00011	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.63e-05	0.00011	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.62e-05	0.000109	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.61e-05	0.000109	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000108	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000108	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000108	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.59e-05	0.000107	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.59e-05	0.000107	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.59e-05	0.000107	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.59e-05	0.000107	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.59e-05	0.000107	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000107	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.58e-05	0.000106	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.57e-05	0.000106	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.57e-05	0.000106	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.56e-05	0.000105	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000105	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.54e-05	0.000104	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.54e-05	0.000104	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.52e-05	0.000102	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000102	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000101	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000101	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.0001	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.48e-05	9.98e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.48e-05	9.97e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.48e-05	9.96e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.48e-05	9.96e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.47e-05	9.9e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.46e-05	9.82e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.44e-05	9.69e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.43e-05	9.67e-05	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.43e-05	9.64e-05	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.42e-05	9.59e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.41e-05	9.49e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.4e-05	9.41e-05	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.38e-05	9.33e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.37e-05	9.22e-05	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.36e-05	9.18e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.36e-05	9.15e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.35e-05	9.11e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.35e-05	9.09e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.34e-05	9.07e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.34e-05	9.05e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.34e-05	9.01e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.3e-05	8.75e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.29e-05	8.71e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.27e-05	8.58e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.27e-05	8.53e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.26e-05	8.47e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.26e-05	8.47e-05	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.26e-05	8.46e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.25e-05	8.46e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.24e-05	8.34e-05	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.23e-05	8.31e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.23e-05	8.28e-05	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.23e-05	8.28e-05	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.22e-05	8.26e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.22e-05	8.21e-05	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.18e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.21e-05	8.16e-05	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.15e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.2e-05	8.12e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.18e-05	7.92e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.17e-05	7.9e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.17e-05	7.88e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.15e-05	7.77e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.14e-05	7.72e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.14e-05	7.68e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.14e-05	7.67e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.13e-05	7.65e-05	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.12e-05	7.58e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.12e-05	7.55e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.12e-05	7.55e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.12e-05	7.52e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.11e-05	7.5e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.1e-05	7.42e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.1e-05	7.4e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.1e-05	7.38e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.09e-05	7.34e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.06e-05	7.17e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.06e-05	7.14e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.05e-05	7.05e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.04e-05	7.04e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.04e-05	7.03e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.04e-05	7.01e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.04e-05	6.99e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	6.99e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.03e-05	6.98e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.03e-05	6.96e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.03e-05	6.93e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.03e-05	6.92e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.02e-05	6.91e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.02e-05	6.88e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.02e-05	6.85e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.01e-05	6.83e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.01e-05	6.81e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.01e-05	6.79e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.01e-05	6.79e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.97e-06	6.72e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.94e-06	6.7e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.91e-06	6.68e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.77e-06	6.59e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.52e-06	6.42e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.46e-06	6.38e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.44e-06	6.36e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.41e-06	6.34e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.38e-06	6.32e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.36e-06	6.31e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.29e-06	6.26e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.26e-06	6.24e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.24e-06	6.23e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.92e-06	6.01e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.8e-06	5.93e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.61e-06	5.8e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.02e-06	5.41e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.95e-06	5.36e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.67e-06	5.17e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.63e-06	5.14e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.42e-06	5e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.3e-06	4.92e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.73e-06	4.54e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.61e-06	4.46e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.59e-06	4.44e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.57e-06	4.43e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.51e-06	4.39e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.49e-06	4.37e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.03e-06	4.06e-05	CbGpPWpGaD
